- 20th Dec 2007
Biopartners terminates collaboration with The Medical House - 20th Aug 2007
Biopartners submits its novel interferon beta-1a, Biferonex®, to the EMEA - 14th Aug 2007
Clinical Phase III Trial Data Demonstrate Valtropin®’s Safety and Efficacy - 29th Mar 2007
Biopartners Appoints New CSO, Dr Conrad Savoy - 14th Mar 2007
Biopartners Holdings AG Purchased by Bioton S.A. - 30th Jun 2006
BioPartners remains positive after Alpheon® CHMP ruling - 4th May 2006
Biopartners Receives European Union Marketing Authorisation for its Biosimilar Recombinant Human Growth Hormone - Valtropin® - 24th Feb 2006
Biopartners Announces CHMP Positive Opinion for its biosimilar Recombinant Human Growth Hormone – Valtropin™
